Entegris Q2 Net Income Jumps 28% on Strong Sales Growth
Ticker: ENTG · Form: 10-Q · Filed: Jul 30, 2025 · CIK: 1101302
Sentiment: bullish
Topics: Semiconductor Materials, Q2 Earnings, Revenue Growth, Net Income Increase, Advanced Materials, Specialty Chemicals, Technology Sector
Related Tickers: ENTG, AMAT, LRCX
TL;DR
**Entegris is crushing it, buy the dip if you can get it, because chip demand isn't slowing down.**
AI Summary
Entegris Inc. reported a net sales increase of 10.2% to $786.1 million for the three months ended June 28, 2025, compared to $713.3 million for the same period in 2024. Net income attributable to Entegris for the second quarter of 2025 was $125.5 million, a significant rise from $98.2 million in the second quarter of 2024, representing a 27.8% increase. Diluted earnings per share also improved to $0.83 in Q2 2025 from $0.65 in Q2 2024. For the six months ended June 28, 2025, net sales reached $1,540.2 million, up from $1,401.5 million in the prior year, an increase of 9.9%. The company's strategic outlook remains positive, driven by strong demand in advanced materials and specialty chemicals, particularly within the semiconductor industry. Key business changes include continued investment in R&D, with expenses at $75.3 million for Q2 2025, up from $68.9 million in Q2 2024, supporting new product development. Risks include ongoing supply chain disruptions and geopolitical tensions, which could impact raw material costs and global sales. The company's cash and cash equivalents stood at $950.1 million as of June 28, 2025, compared to $875.6 million at December 31, 2024.
Why It Matters
Entegris's robust Q2 performance, with a 27.8% increase in net income, signals strong demand in the semiconductor materials market, benefiting investors through improved profitability and EPS. This growth reflects the company's critical role in the advanced technology supply chain, providing essential materials and solutions to chip manufacturers. For employees, this indicates job security and potential for growth within a thriving sector. Customers can expect continued innovation and reliable supply from a key partner. In the broader market, Entegris's success underscores the ongoing expansion and resilience of the semiconductor industry, potentially impacting competitors like Applied Materials and Lam Research by setting a high bar for performance and innovation.
Risk Assessment
Risk Level: low — The risk level is low due to strong financial performance, with net sales increasing by 10.2% and net income by 27.8% in Q2 2025. The company also maintains a healthy cash position of $950.1 million as of June 28, 2025, providing a buffer against unforeseen challenges. While geopolitical tensions are mentioned, the company's consistent growth and critical role in the semiconductor supply chain mitigate immediate financial risks.
Analyst Insight
Investors should consider holding or increasing their position in ENTG, given the strong Q2 2025 financial results and positive outlook for the semiconductor industry. The company's consistent revenue and net income growth, coupled with strategic R&D investments, suggest continued market leadership and shareholder value creation.
Financial Highlights
- revenue
- $786.1M
- net Income
- $125.5M
- eps
- $0.83
- cash Position
- $950.1M
- revenue Growth
- +10.2%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Semiconductor Solutions | $786.1M | +10.2% |
Key Numbers
- $786.1M — Net Sales for Q2 2025 (Increased by 10.2% from $713.3 million in Q2 2024)
- $125.5M — Net Income for Q2 2025 (Increased by 27.8% from $98.2 million in Q2 2024)
- $0.83 — Diluted EPS for Q2 2025 (Increased from $0.65 in Q2 2024)
- $1,540.2M — Net Sales for Six Months Ended June 28, 2025 (Increased by 9.9% from $1,401.5 million in the prior year period)
- $75.3M — Research and Development Expenses for Q2 2025 (Increased from $68.9 million in Q2 2024, indicating continued investment)
- $950.1M — Cash and Cash Equivalents as of June 28, 2025 (Increased from $875.6 million at December 31, 2024)
Key Players & Entities
- ENTEGRIS INC (company) — filer of the 10-Q
- Bloomberg (company) — publisher of the analysis
- Applied Materials (company) — competitor in the semiconductor industry
- Lam Research (company) — competitor in the semiconductor industry
- SEC (regulator) — recipient of the 10-Q filing
FAQ
What were Entegris's net sales for the second quarter of 2025?
Entegris's net sales for the second quarter of 2025 were $786.1 million, an increase of 10.2% compared to $713.3 million in the second quarter of 2024.
How did Entegris's net income change in Q2 2025 compared to Q2 2024?
Entegris's net income attributable to Entegris increased by 27.8% to $125.5 million in Q2 2025, up from $98.2 million in Q2 2024.
What was Entegris's diluted earnings per share for the second quarter of 2025?
Entegris reported diluted earnings per share of $0.83 for the second quarter of 2025, an increase from $0.65 in the second quarter of 2024.
What are the key drivers of Entegris's revenue growth?
The key drivers of Entegris's revenue growth are strong demand in advanced materials and specialty chemicals, particularly within the semiconductor industry, as evidenced by the 10.2% increase in net sales.
What risks does Entegris highlight in its 10-Q filing?
Entegris highlights ongoing supply chain disruptions and geopolitical tensions as potential risks that could impact raw material costs and global sales, though strong performance mitigates immediate financial concerns.
How much did Entegris invest in research and development in Q2 2025?
Entegris invested $75.3 million in research and development expenses for Q2 2025, an increase from $68.9 million in Q2 2024, demonstrating continued commitment to innovation.
What is Entegris's cash position as of June 28, 2025?
As of June 28, 2025, Entegris's cash and cash equivalents stood at $950.1 million, an increase from $875.6 million at December 31, 2024.
How does Entegris's performance impact the broader semiconductor market?
Entegris's strong performance, with significant increases in net sales and net income, indicates robust health in the semiconductor materials sector, suggesting continued growth and demand for advanced chip manufacturing components.
What is the strategic outlook for Entegris based on this filing?
The strategic outlook for Entegris remains positive, driven by strong demand in advanced materials and specialty chemicals, and continued investment in R&D to support new product development for the semiconductor industry.
Should investors be concerned about Entegris's debt levels?
The filing does not provide specific details on debt levels, but the significant increase in cash and cash equivalents to $950.1 million suggests a healthy liquidity position, which typically reduces concerns about debt management.
Risk Factors
- Supply Chain Disruptions [high — operational]: Ongoing supply chain disruptions pose a risk to Entegris's operations, potentially impacting raw material availability and costs. The company's ability to manage these disruptions will be crucial for maintaining production levels and profitability.
- Geopolitical Tensions [medium — market]: Geopolitical tensions can lead to volatility in global markets, affecting Entegris's international sales and potentially increasing the cost of goods. These tensions may also influence customer demand for semiconductor-related products.
- Raw Material Cost Volatility [medium — financial]: Fluctuations in the cost of raw materials, exacerbated by supply chain issues and geopolitical factors, present a financial risk. Entegris must effectively manage these costs to protect its gross margins.
Industry Context
Entegris operates within the highly specialized semiconductor materials and chemicals sector. The industry is characterized by rapid technological advancements, significant R&D investment, and a cyclical demand driven by global semiconductor production. Key trends include the increasing complexity of chip manufacturing, the demand for advanced materials for next-generation devices, and a growing emphasis on supply chain resilience.
Regulatory Implications
While no specific new regulatory changes were highlighted, Entegris, like all companies in the chemical and manufacturing sectors, must adhere to environmental, health, and safety regulations. Compliance with these standards is crucial to avoid fines, operational disruptions, and reputational damage.
What Investors Should Do
- Monitor R&D Spending
- Assess Supply Chain Resilience
- Analyze Margin Trends
Key Dates
- 2025-06-28: End of Second Quarter 2025 — Reported net sales of $786.1 million and net income of $125.5 million, demonstrating significant year-over-year growth.
- 2025-06-28: Cash and Cash Equivalents Balance — Company reported $950.1 million in cash and cash equivalents, an increase from year-end 2024, indicating strong liquidity.
- 2025-06-28: Research and Development Expenses — R&D expenses were $75.3 million, up from $68.9 million in Q2 2024, highlighting continued investment in innovation.
Glossary
- Net Sales
- The total revenue generated from the sale of goods or services, net of returns, allowances, and discounts. (Key indicator of top-line performance and market demand for Entegris's products.)
- Diluted Earnings Per Share (EPS)
- A measure of a company's profit allocated to each outstanding share of common stock, assuming all convertible securities and stock options were exercised. (Reflects the profitability available to common shareholders on a fully diluted basis.)
- Cash and Cash Equivalents
- Short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. (Indicates the company's immediate liquidity and financial flexibility.)
- Research and Development Expenses
- Costs incurred by a company in the process of developing new products or services, or improving existing ones. (Shows the company's commitment to innovation and future growth drivers.)
Year-Over-Year Comparison
Entegris Inc. has demonstrated robust performance compared to the prior year's comparable period. Net sales for the second quarter of 2025 increased by 10.2% to $786.1 million, and net income saw a substantial rise of 27.8% to $125.5 million, leading to improved diluted EPS of $0.83. The company also increased its investment in research and development, with expenses rising to $75.3 million, signaling a focus on future growth. The cash position has strengthened to $950.1 million. New risks highlighted include ongoing supply chain disruptions and geopolitical tensions, which were not as prominently featured in previous reports.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on July 30, 2025 regarding ENTEGRIS INC (ENTG).